Xenon offers stable haemodynamics independent of induced hypothermia after hypoxia–ischaemia in newborn pigs
- 276 Downloads
To assess the effect of 18 hour (h) 50% xenon (Xe) inhalation at normothermia (NT, 38.5°C) or hypothermia (HT, 33.5°C) on mean arterial blood pressure (MABP), inotropic support and heart rate (HR) following an induced perinatal global hypoxic−ischaemic insult (HI) in newborn pigs.
Newborn pigs ventilated under inhalational anaesthesia, following a 45 min HI (inhaled oxygen fraction reduced until amplitude integrated electroencephalogram was less than 7 μV), were randomised to three Xe (n = 45) (50% Xe 18 h with NT, HT 12 h or HT 24 h) or three non-Xe groups (n = 53) (0% Xe with NT, HT 12 h or HT 24 h) under otherwise identical conditions. We measured MABP and HR every minute. Hypotension (MABP <40 mmHg) was treated sequentially with 2 × 10 mL/kg saline, dopamine, norepinephrine and hydrocortisone if required.
Xe maintained higher MABP during HT (5.1 mmHg, 95% CI 2.34, 7.89), rewarming (10.1 mmHg, 95% CI 6.26, 13.95) and after cessation (4.1 mmHg, 95% CI 0.37, 7.84) independent of HT, inotropic support and acidosis. Xe reduced the duration of inotropic support by 12.6 h (95% CI 5.5, 19.73). Inotropic support decreased the HR reduction induced by HT from 9 to 5 bpm/°C during cooling and from 10−7 to 4−3 bpm/°C during rewarming. There was no interaction between Xe, HT, inotropic support and acidosis. Xe during HT cleared lactate faster; 3 h post-HI median (IQR) values of (Xe HT) 2.8 mmol/L (0.9, 3.1) vs. (HT) 5.9 mmol/L (2.5, 7.9), p = 0.0004.
Xe maintained stable blood pressure, thereby reducing the inotropic support requirements during and after administration independently of induced HT—current neonatal encephalopathy treatment. Xe may offer haemodynamic benefits in clinical neuroprotection studies.
KeywordsXenon Hypotension Inotrope Induced hypothermia Hypoxic ischaemia Pig
- 2.Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH (2005) Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353:1574–1584PubMedCrossRefGoogle Scholar
- 5.Haaland K, Loberg EM, Steen PA, Satas S, Thoresen M (1997) The effect of mild post-hypoxic hypothermia on organ pathology in a piglet survival model of global hypoxia. Prenat Neonat Med 2:329–337Google Scholar
- 13.Rossaint R, Reyle-Hahn M, Schulte Am Esch J, Scholz J, Scherpereel P, Vallet B, Giunta F, Del Turco M, Erdmann W, Tenbrinck R, Hammerle AF, Nagele P (2003) Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 98:6–13PubMedCrossRefGoogle Scholar
- 15.Fugelseth D, Satas S, Steen PA, Thoresen M (2003) Cardiac output, pulmonary artery pressure, and patent ductus arteriosus during therapeutic cooling after global hypoxia-ischaemia. Arch Dis Child 88:F223–F228Google Scholar
- 16.Thoresen M (2011) The cool xenon study. Available from http://www.controlled-trials.com/ISRCTN75602528. Accessed 11 Nov 2011
- 23.TOBY study group (2010) Cardiovascular support. In: TOBY study handbook, phase 2. National Perinatal Epidemiology Unit, Oxford, p 16. Available via http://www.npeu.ox.ac.uk/files/downloads/toby/TOBY-Handbook-Phase-2.pdf. Accessed 28 Oct 2011
- 30.Thoresen M (2008) Supportive care during neuroprotective hypothermia in the term newborn: adverse effects and their prevention. Clin Perinatol 35:749−763, viiGoogle Scholar